questionsmedicales.fr
Techniques d'investigation
Techniques de laboratoire clinique
Tests de chimie clinique
Tests de chimie clinique : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Tests de fonction hépatique
Bilirubine
Transaminases
Profil lipidique
Cholestérol
Triglycérides
Créatinine
Fonction rénale
Taux de filtration glomérulaire
Protéine C-réactive
Inflammation
Marqueurs biologiques
Symptômes
5
Maladie hépatique
Symptômes
Jaunisse
Diabète
Symptômes
Fatigue
Cholestérol
Symptômes
Maladie cardiaque
Insuffisance rénale
Symptômes
Enflure
Inflammation
Symptômes
Douleur
Prévention
5
Maladies hépatiques
Prévention
Vaccination
Diabète
Prévention
Alimentation équilibrée
Hyperlipidémie
Prévention
Alimentation saine
Insuffisance rénale
Prévention
Hypertension
Inflammation
Prévention
Alimentation anti-inflammatoire
Traitements
5
Maladie hépatique
Traitement
Chirurgie
Diabète de type 2
Traitement
Médicaments antidiabétiques
Hyperlipidémie
Statines
Changements alimentaires
Insuffisance rénale
Dialyse
Transplantation rénale
Inflammation chronique
Anti-inflammatoires
Corticostéroïdes
Complications
5
Maladies hépatiques
Complications
Cirrhose
Diabète
Complications
Maladies cardiaques
Hyperlipidémie
Complications
AVC
Insuffisance rénale
Complications
Anémie
Inflammation chronique
Complications
Maladies auto-immunes
Facteurs de risque
5
Maladies hépatiques
Facteurs de risque
Obésité
Diabète
Facteurs de risque
Antécédents familiaux
Hyperlipidémie
Facteurs de risque
Tabagisme
Insuffisance rénale
Facteurs de risque
Hypertension
Inflammation chronique
Facteurs de risque
Alimentation déséquilibrée
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Tests de chimie clinique : Questions médicales les plus fréquentes",
"headline": "Tests de chimie clinique : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Tests de chimie clinique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-02",
"dateModified": "2025-04-27",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Tests de chimie clinique"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Techniques de laboratoire clinique",
"url": "https://questionsmedicales.fr/mesh/D019411",
"about": {
"@type": "MedicalCondition",
"name": "Techniques de laboratoire clinique",
"code": {
"@type": "MedicalCode",
"code": "D019411",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E05.200"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Analyse chimique du sang",
"alternateName": "Blood Chemical Analysis",
"url": "https://questionsmedicales.fr/mesh/D001774",
"about": {
"@type": "MedicalCondition",
"name": "Analyse chimique du sang",
"code": {
"@type": "MedicalCode",
"code": "D001774",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E05.200.124.100"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Gazométrie sanguine",
"alternateName": "Blood Gas Analysis",
"url": "https://questionsmedicales.fr/mesh/D001784",
"about": {
"@type": "MedicalCondition",
"name": "Gazométrie sanguine",
"code": {
"@type": "MedicalCode",
"code": "D001784",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E05.200.124.100.100"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Oxymétrie",
"alternateName": "Oximetry",
"url": "https://questionsmedicales.fr/mesh/D010092",
"about": {
"@type": "MedicalCondition",
"name": "Oxymétrie",
"code": {
"@type": "MedicalCode",
"code": "D010092",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E05.200.124.100.100.600"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Surveillance transcutanée des gaz du sang",
"alternateName": "Blood Gas Monitoring, Transcutaneous",
"url": "https://questionsmedicales.fr/mesh/D001785",
"about": {
"@type": "MedicalCondition",
"name": "Surveillance transcutanée des gaz du sang",
"code": {
"@type": "MedicalCode",
"code": "D001785",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E05.200.124.100.100.600.100"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Surveillance transcutanée des gaz du sang",
"alternateName": "Blood Gas Monitoring, Transcutaneous",
"url": "https://questionsmedicales.fr/mesh/D001785",
"about": {
"@type": "MedicalCondition",
"name": "Surveillance transcutanée des gaz du sang",
"code": {
"@type": "MedicalCode",
"code": "D001785",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E05.200.124.100.100.600.100"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Oxymétrie",
"alternateName": "Oximetry",
"url": "https://questionsmedicales.fr/mesh/D010092",
"about": {
"@type": "MedicalCondition",
"name": "Oxymétrie",
"code": {
"@type": "MedicalCode",
"code": "D010092",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E05.200.124.100.100.600"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Surveillance transcutanée des gaz du sang",
"alternateName": "Blood Gas Monitoring, Transcutaneous",
"url": "https://questionsmedicales.fr/mesh/D001785",
"about": {
"@type": "MedicalCondition",
"name": "Surveillance transcutanée des gaz du sang",
"code": {
"@type": "MedicalCode",
"code": "D001785",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E05.200.124.100.100.600.100"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Surveillance transcutanée des gaz du sang",
"alternateName": "Blood Gas Monitoring, Transcutaneous",
"url": "https://questionsmedicales.fr/mesh/D001785",
"about": {
"@type": "MedicalCondition",
"name": "Surveillance transcutanée des gaz du sang",
"code": {
"@type": "MedicalCode",
"code": "D001785",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E05.200.124.100.100.600.100"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Autosurveillance glycémique",
"alternateName": "Blood Glucose Self-Monitoring",
"url": "https://questionsmedicales.fr/mesh/D015190",
"about": {
"@type": "MedicalCondition",
"name": "Autosurveillance glycémique",
"code": {
"@type": "MedicalCode",
"code": "D015190",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E05.200.124.100.105"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Azote uréique sanguin",
"alternateName": "Blood Urea Nitrogen",
"url": "https://questionsmedicales.fr/mesh/D001806",
"about": {
"@type": "MedicalCondition",
"name": "Azote uréique sanguin",
"code": {
"@type": "MedicalCode",
"code": "D001806",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E05.200.124.100.115"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Panel métabolique complet",
"alternateName": "Comprehensive Metabolic Panel",
"url": "https://questionsmedicales.fr/mesh/D000093182",
"about": {
"@type": "MedicalCondition",
"name": "Panel métabolique complet",
"code": {
"@type": "MedicalCode",
"code": "D000093182",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E05.200.124.100.174"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dépistage sur goutte de sang séché",
"alternateName": "Dried Blood Spot Testing",
"url": "https://questionsmedicales.fr/mesh/D059788",
"about": {
"@type": "MedicalCondition",
"name": "Dépistage sur goutte de sang séché",
"code": {
"@type": "MedicalCode",
"code": "D059788",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E05.200.124.100.232"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Technique du clamp glycémique",
"alternateName": "Glucose Clamp Technique",
"url": "https://questionsmedicales.fr/mesh/D015309",
"about": {
"@type": "MedicalCondition",
"name": "Technique du clamp glycémique",
"code": {
"@type": "MedicalCode",
"code": "D015309",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E05.200.124.100.350"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Hyperglycémie provoquée",
"alternateName": "Glucose Tolerance Test",
"url": "https://questionsmedicales.fr/mesh/D005951",
"about": {
"@type": "MedicalCondition",
"name": "Hyperglycémie provoquée",
"code": {
"@type": "MedicalCode",
"code": "D005951",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E05.200.124.100.355"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Test de tolérance au lactose",
"alternateName": "Lactose Tolerance Test",
"url": "https://questionsmedicales.fr/mesh/D007789",
"about": {
"@type": "MedicalCondition",
"name": "Test de tolérance au lactose",
"code": {
"@type": "MedicalCode",
"code": "D007789",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E05.200.124.100.450"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Tests enzymatiques en clinique",
"alternateName": "Clinical Enzyme Tests",
"url": "https://questionsmedicales.fr/mesh/D004796",
"about": {
"@type": "MedicalCondition",
"name": "Tests enzymatiques en clinique",
"code": {
"@type": "MedicalCode",
"code": "D004796",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E05.200.124.200"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Mesure de l'acidité gastrique",
"alternateName": "Gastric Acidity Determination",
"url": "https://questionsmedicales.fr/mesh/D005745",
"about": {
"@type": "MedicalCondition",
"name": "Mesure de l'acidité gastrique",
"code": {
"@type": "MedicalCode",
"code": "D005745",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E05.200.124.300"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Analyse de cheveux",
"alternateName": "Hair Analysis",
"url": "https://questionsmedicales.fr/mesh/D000081205",
"about": {
"@type": "MedicalCondition",
"name": "Analyse de cheveux",
"code": {
"@type": "MedicalCode",
"code": "D000081205",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E05.200.124.385"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Examen des urines",
"alternateName": "Urinalysis",
"url": "https://questionsmedicales.fr/mesh/D016482",
"about": {
"@type": "MedicalCondition",
"name": "Examen des urines",
"code": {
"@type": "MedicalCode",
"code": "D016482",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E05.200.124.810"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Analyse des sédiments urinaires",
"alternateName": "Urinary Sediment Analysis",
"url": "https://questionsmedicales.fr/mesh/D000095025",
"about": {
"@type": "MedicalCondition",
"name": "Analyse des sédiments urinaires",
"code": {
"@type": "MedicalCode",
"code": "D000095025",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E05.200.124.810.500"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Tests de chimie clinique",
"alternateName": "Clinical Chemistry Tests",
"code": {
"@type": "MedicalCode",
"code": "D019963",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Christoph Leineweber",
"url": "https://questionsmedicales.fr/author/Christoph%20Leineweber",
"affiliation": {
"@type": "Organization",
"name": "Laboklin GmbH & Co. KG, 97688 Bad Kissingen, Germany, christoph.leineweber@outlook.de."
}
},
{
"@type": "Person",
"name": "Brandon J Tenney",
"url": "https://questionsmedicales.fr/author/Brandon%20J%20Tenney",
"affiliation": {
"@type": "Organization",
"name": "Department of Pathology, Johns Hopkins Medical Institutes, Baltimore, MD, United States."
}
},
{
"@type": "Person",
"name": "Mark A Marzinke",
"url": "https://questionsmedicales.fr/author/Mark%20A%20Marzinke",
"affiliation": {
"@type": "Organization",
"name": "Department of Pathology, Johns Hopkins Medical Institutes, Baltimore, MD, United States. Electronic address: mmarzin1@jhmi.edu."
}
},
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Anna E Merrill",
"url": "https://questionsmedicales.fr/author/Anna%20E%20Merrill",
"affiliation": {
"@type": "Organization",
"name": "Department of Pathology, University of Iowa Hospitals and Clinics, 200 Hawkins Drive, C-671 GH, Iowa City, IA 52242, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Serum prostate specific antigen is a good indicator of prostatic volume in men with benign prostatic hyperplasia.",
"datePublished": "2022-12-15",
"url": "https://questionsmedicales.fr/article/36546488",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.4102/phcfm.v14i1.3736"
}
},
{
"@type": "ScholarlyArticle",
"name": "Granulomatous prostatitis: mimicking locally advanced prostate adenocarcinoma.",
"datePublished": "2023-10-17",
"url": "https://questionsmedicales.fr/article/37850783",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.23750/abm.v94i5.13751"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prostatic Artery Embolization Versus Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia: A Cost-Effectiveness Analysis.",
"datePublished": "2022-08-12",
"url": "https://questionsmedicales.fr/article/35964881",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jvir.2022.08.006"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prostate organogenesis.",
"datePublished": "2022-06-21",
"url": "https://questionsmedicales.fr/article/35726824",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1242/dev.200394"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prostatic Urethral Length as a Predictor for Surgery in Benign Prostatic Hyperplasia.",
"datePublished": "2023-03-10",
"url": "https://questionsmedicales.fr/article/36974872",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.33314/jnhrc.v20i3.4613"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Techniques d'investigation",
"item": "https://questionsmedicales.fr/mesh/D008919"
},
{
"@type": "ListItem",
"position": 3,
"name": "Techniques de laboratoire clinique",
"item": "https://questionsmedicales.fr/mesh/D019411"
},
{
"@type": "ListItem",
"position": 4,
"name": "Tests de chimie clinique",
"item": "https://questionsmedicales.fr/mesh/D019963"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Tests de chimie clinique - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Tests de chimie clinique",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-17",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Tests de chimie clinique",
"description": "Quels tests évaluent la fonction hépatique ?\nComment détecter le diabète avec des tests ?\nQuels tests mesurent les lipides sanguins ?\nQuel test évalue la fonction rénale ?\nComment évaluer l'inflammation dans le corps ?",
"url": "https://questionsmedicales.fr/mesh/D019963?mesh_terms=Prostate#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Tests de chimie clinique",
"description": "Quels symptômes indiquent une maladie hépatique ?\nQuels signes révèlent un diabète ?\nQuels symptômes sont liés à des niveaux élevés de cholestérol ?\nQuels symptômes indiquent une insuffisance rénale ?\nQuels signes d'inflammation sont courants ?",
"url": "https://questionsmedicales.fr/mesh/D019963?mesh_terms=Prostate#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Tests de chimie clinique",
"description": "Comment prévenir les maladies hépatiques ?\nQuelles mesures pour prévenir le diabète ?\nComment prévenir l'hyperlipidémie ?\nQuelles stratégies pour prévenir l'insuffisance rénale ?\nComment réduire l'inflammation dans le corps ?",
"url": "https://questionsmedicales.fr/mesh/D019963?mesh_terms=Prostate#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Tests de chimie clinique",
"description": "Comment traiter une maladie hépatique ?\nQuel traitement pour le diabète de type 2 ?\nComment gérer l'hyperlipidémie ?\nQuel traitement pour l'insuffisance rénale ?\nComment traiter l'inflammation chronique ?",
"url": "https://questionsmedicales.fr/mesh/D019963?mesh_terms=Prostate#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Tests de chimie clinique",
"description": "Quelles complications des maladies hépatiques ?\nQuelles complications du diabète ?\nQuelles complications de l'hyperlipidémie ?\nQuelles complications de l'insuffisance rénale ?\nQuelles complications de l'inflammation chronique ?",
"url": "https://questionsmedicales.fr/mesh/D019963?mesh_terms=Prostate#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Tests de chimie clinique",
"description": "Quels facteurs de risque pour les maladies hépatiques ?\nQuels facteurs de risque pour le diabète ?\nQuels facteurs de risque pour l'hyperlipidémie ?\nQuels facteurs de risque pour l'insuffisance rénale ?\nQuels facteurs de risque pour l'inflammation chronique ?",
"url": "https://questionsmedicales.fr/mesh/D019963?mesh_terms=Prostate#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Quels tests évaluent la fonction hépatique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests de la fonction hépatique incluent les transaminases, la bilirubine et les phosphatases alcalines."
}
},
{
"@type": "Question",
"name": "Comment détecter le diabète avec des tests ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le dosage de la glycémie à jeun et l'HbA1c sont utilisés pour diagnostiquer le diabète."
}
},
{
"@type": "Question",
"name": "Quels tests mesurent les lipides sanguins ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le profil lipidique mesure le cholestérol total, LDL, HDL et les triglycérides."
}
},
{
"@type": "Question",
"name": "Quel test évalue la fonction rénale ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "La créatinine sérique et le taux de filtration glomérulaire (TFG) évaluent la fonction rénale."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'inflammation dans le corps ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "La protéine C-réactive (CRP) est un marqueur utilisé pour évaluer l'inflammation."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une maladie hépatique ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent la jaunisse, la fatigue, des douleurs abdominales et des démangeaisons."
}
},
{
"@type": "Question",
"name": "Quels signes révèlent un diabète ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent une soif excessive, des mictions fréquentes, et une fatigue persistante."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à des niveaux élevés de cholestérol ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Souvent asymptomatique, mais peut causer des douleurs thoraciques ou des crises cardiaques."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une insuffisance rénale ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent l'enflure, la fatigue, des changements dans la miction et des démangeaisons."
}
},
{
"@type": "Question",
"name": "Quels signes d'inflammation sont courants ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Rougeur, chaleur, gonflement et douleur sont des signes d'inflammation dans le corps."
}
},
{
"@type": "Question",
"name": "Comment prévenir les maladies hépatiques ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter l'alcool, maintenir un poids santé et se faire vacciner contre l'hépatite."
}
},
{
"@type": "Question",
"name": "Quelles mesures pour prévenir le diabète ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Adopter une alimentation équilibrée, faire de l'exercice et surveiller le poids."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'hyperlipidémie ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation saine, l'exercice régulier et éviter le tabac sont essentiels."
}
},
{
"@type": "Question",
"name": "Quelles stratégies pour prévenir l'insuffisance rénale ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Contrôler la pression artérielle, gérer le diabète et rester hydraté sont cruciaux."
}
},
{
"@type": "Question",
"name": "Comment réduire l'inflammation dans le corps ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation anti-inflammatoire, l'exercice et la gestion du stress aident à réduire l'inflammation."
}
},
{
"@type": "Question",
"name": "Comment traiter une maladie hépatique ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement dépend de la cause, incluant médicaments, changements de mode de vie ou chirurgie."
}
},
{
"@type": "Question",
"name": "Quel traitement pour le diabète de type 2 ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement inclut des médicaments, des modifications alimentaires et de l'exercice physique."
}
},
{
"@type": "Question",
"name": "Comment gérer l'hyperlipidémie ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les statines, les changements alimentaires et l'exercice sont des approches courantes."
}
},
{
"@type": "Question",
"name": "Quel traitement pour l'insuffisance rénale ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement peut inclure des médicaments, dialyse ou transplantation rénale selon la gravité."
}
},
{
"@type": "Question",
"name": "Comment traiter l'inflammation chronique ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les anti-inflammatoires, les corticostéroïdes et les modifications du mode de vie sont utilisés."
}
},
{
"@type": "Question",
"name": "Quelles complications des maladies hépatiques ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la cirrhose, le cancer du foie et l'insuffisance hépatique."
}
},
{
"@type": "Question",
"name": "Quelles complications du diabète ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent les maladies cardiaques, les neuropathies et les problèmes rénaux."
}
},
{
"@type": "Question",
"name": "Quelles complications de l'hyperlipidémie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hyperlipidémie peut entraîner des maladies cardiovasculaires et des AVC."
}
},
{
"@type": "Question",
"name": "Quelles complications de l'insuffisance rénale ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'anémie, les maladies osseuses et les maladies cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Quelles complications de l'inflammation chronique ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'inflammation chronique peut causer des maladies auto-immunes et des cancers."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour les maladies hépatiques ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'alcoolisme, l'obésité et les infections virales sont des facteurs de risque majeurs."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour le diabète ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'obésité, l'inactivité physique et les antécédents familiaux augmentent le risque de diabète."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour l'hyperlipidémie ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en graisses saturées, le tabagisme et l'inactivité physique sont des risques."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour l'insuffisance rénale ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hypertension, le diabète et les antécédents familiaux de maladies rénales sont des risques."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour l'inflammation chronique ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabagisme, l'obésité et une alimentation déséquilibrée augmentent le risque d'inflammation."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 27/04/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Laboklin GmbH & Co. KG, 97688 Bad Kissingen, Germany, christoph.leineweber@outlook.de.
Publications dans "Tests de chimie clinique" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology, Johns Hopkins Medical Institutes, Baltimore, MD, United States.
Publications dans "Tests de chimie clinique" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology, Johns Hopkins Medical Institutes, Baltimore, MD, United States. Electronic address: mmarzin1@jhmi.edu.
Publications dans "Tests de chimie clinique" :
2 publications dans cette catégorie
Publications dans "Tests de chimie clinique" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology, University of Iowa Hospitals and Clinics, 200 Hawkins Drive, C-671 GH, Iowa City, IA 52242, USA.
Publications dans "Tests de chimie clinique" :
2 publications dans cette catégorie
Affiliations :
Carver College of Medicine, University of Iowa, 451 Newton Road, Iowa City, IA 52242, USA.
Department of Psychiatry and Behavioral Sciences, University of Kansas School of Medicine-Wichita, Wichita, KS 67214, USA.
Publications dans "Tests de chimie clinique" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology, University of Iowa Hospitals and Clinics, 200 Hawkins Drive, C-671 GH, Iowa City, IA 52242, USA.
Publications dans "Tests de chimie clinique" :
2 publications dans cette catégorie
Affiliations :
Department of Laboratory Medicine, National University Hospital, Singapore.
Publications dans "Tests de chimie clinique" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology and Laboratory Medicine, Jigme Dorji Wangchuck National Referral Hospital, Thimphu, Bhutan.
Publications dans "Tests de chimie clinique" :
2 publications dans cette catégorie
Affiliations :
Section of Clinical Biochemistry, University Hospital of Verona, Verona, Italy.
Publications dans "Tests de chimie clinique" :
2 publications dans cette catégorie
Affiliations :
Faculty of Veterinary Medicine, Okayama University of Science, Imabari, Ehime, Japan.
Biomedical Science Examination and Research Center, Okayama University of Science, Imabari, Ehime, Japan.
Publications dans "Tests de chimie clinique" :
2 publications dans cette catégorie
Affiliations :
Faculty of Veterinary Medicine, Okayama University of Science, Imabari, Ehime, Japan.
Biomedical Science Examination and Research Center, Okayama University of Science, Imabari, Ehime, Japan.
Publications dans "Tests de chimie clinique" :
2 publications dans cette catégorie
Affiliations :
Biomedical Science Examination and Research Center, Okayama University of Science, Imabari, Ehime, Japan.
Publications dans "Tests de chimie clinique" :
2 publications dans cette catégorie
Affiliations :
Biomedical Science Examination and Research Center, Okayama University of Science, Imabari, Ehime, Japan.
Publications dans "Tests de chimie clinique" :
2 publications dans cette catégorie
Affiliations :
Biomedical Science Examination and Research Center, Okayama University of Science, Imabari, Ehime, Japan.
Publications dans "Tests de chimie clinique" :
2 publications dans cette catégorie
Affiliations :
Faculty of Veterinary Medicine, Okayama University of Science, Imabari, Ehime, Japan.
Publications dans "Tests de chimie clinique" :
2 publications dans cette catégorie
Affiliations :
Tierpark Hellabrunn, 81543 Munich, Germany.
Publications dans "Tests de chimie clinique" :
2 publications dans cette catégorie
Affiliations :
Laboklin GmbH & Co. KG, 97688 Bad Kissingen, Germany.
Publications dans "Tests de chimie clinique" :
2 publications dans cette catégorie
Affiliations :
Tierpark Hellabrunn, 81543 Munich, Germany.
Publications dans "Tests de chimie clinique" :
2 publications dans cette catégorie
Affiliations :
Department of Companion Animal Clinical Studies, Faculty of Veterinary Science, Centre for Veterinary Wildlife Studies, University of Pretoria, Pretoria, South Africa.
Publications dans "Tests de chimie clinique" :
Benign prostatic hyperplasia (BPH) is the most common cause of bladder outlet obstruction in men over the age of 50 years. An association between the prostate specific antigen (PSA), International Pro...
To determine the correlation between the PSA, IPSS and PV in men of African descent....
This was a cross sectional analysis involving 92 patients diagnosed as having symptomatic BPH at the Ho Teaching Hospital....
The data were collected using standardised questionnaires. The IPSS determined urinary symptom severity. The PV was determined using a transabdominal ultrasound machine. Serum PSA was retrieved from t...
The mean PV was 61.04 cm3 ± 21.95 cm3, the mean PSA was 4.21 ng/mL ± 3.85 ng/mL, and mean IPSS of 21.59 ± 3.78. The Pearson's correlation between PV and PSA was 0.283 (p = 0.01), between PV and IPSS w...
This study showed that serum PSA has a positive correlation with PV. However, IPSS had no significant association with PSA or PV in patients with BPH.Contribution: This study provides insights into th...
We report the case of a 63-year-old male who came to the urology clinic with an increasing value of the prostate specific antigen and an asymmetrical enlargement at the digital rectal examination. The...
To compare the cost effectiveness of prostatic artery embolization (PAE) with that of transurethral resection of the prostate (TURP) for the treatment of medically refractory benign prostatic hyperpla...
A cost-effectiveness analysis with Markov modeling was performed, comparing the clinical course after PAE with that after TURP for 3 years. Probabilities were obtained from the available literature, a...
Base case calculation showed comparable outcomes (PAE, 2.845 QALY; TURP, 2.854 QALY), with a cost difference of $3,104 (PAE, $2,934; TURP, $6,038). The incremental cost-effectiveness ratio was $360,24...
PAE is a cost-effective strategy to treat medically refractory BPH, resulting in comparable health benefits at a lower cost than that of TURP even when accounting for extreme alterations in adverse ev...
Prostate organogenesis begins during embryonic development and continues through puberty when the prostate becomes an important exocrine gland of the male reproductive system. The specification and gr...
Benign prostatic hyperplasia is associated with structural and morphological changes including elongation of prostatic urethral length. The aim of our study was to assess whether prostatic urethral le...
This prospective observational study was conducted over a 12-months duration. All the patients who presented with lower urinary tract symptoms secondary to benign prostatic hyperplasia were evaluated ...
A total of 153 patients were included in the study. Eighty-three (54.2%) patients underwent surgery during the study period. Prostate volume, intravesical prostatic protrusion, post-void residual volu...
BPH patients with longer PUL may require surgical management. PUL measured by TRUS may be a predicting factor for the need of surgery in BPH Keywords: Benign prostatic hyperplasia; lower urinary tract...
Biomarkers of DNA damage repair deficiency provide opportunities for personalized treatment with immunotherapy. However, there is limited research on the immune microenvironment of adeno-neuroendocrin...
A retrospective medical record review of 66 patients with prostate cancer (PCa) was performed. PCa samples from the 66 patients were analyzed using immunohistochemical staining for the detection of ch...
Twenty patients presented with adeno-NEPC, whereas 46 presented with adeno-PCa. The median age of patients at PCa diagnosis was 67.86 ± 7.05 years (68.65 ± 7.23 years, adeno-NEPC; 67.52 ± 7.02 years, ...
Our study revealed clinicopathological manifestations of adeno-NEPC and some possible predictive factors significantly associated with better outcomes in patients with adeno-NEPC. These findings might...
The purpose of the study was to evaluate the diagnostic significance of two new and a few clinical markers for prostate cancer (PCa) at various prostate volumes (PV)....
The study subjects were divided into two groups. Among them, there were 70 cases in the PV ≤30 ml group (benign prostatic hyperplasia [BPH]: 32 cases, PCa: 38 cases) and 372 cases in the PV > 30 ml gr...
In the PV ≤30 ml group, the diagnostic parameters based on prostate-specific antigen (PSA) had a decreased diagnostic significance for PCa. In the PV > 30 ml group, PSAD (AUC = 0.709), AVR (AVR = Age/...
Choosing appropriate indicators for different PVs could contribute to the early screening and diagnosis of PCa. The difference in the diagnostic value of two new indicators (A-PSAD and AVR), and PSAD ...
Holmium laser enucleation of the prostate (HoLEP) is a size-independent surgical option for treating benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS) with excellent, durable ...
This study aims to compare the ability of the PHI versus tPSA test to predict the presence of PCa in our population....
A prospective observational study was performed. We included patients with tPSA ≥ 2.5 ng/ml, biopsy naïve or previous negative biopsy, undergoing a blood test, which includes tPSA, fPSA, and p2PSA, an...
140 men were included. Fifty-seven (40.7%) had a positive prostate biopsy result (Group A), and 83 (59.3%) had a negative biopsy result (Group B). The mean age was similar in both groups (mean ± stand...
The PHI test improves PCa detection compared to tPSA in our population....
We compare Prostate Health Index, Prostate Health Index density, and PSA density in predicting clinically significant prostate cancer in MRI-guided prostate biopsy....
This is a multicenter evaluation of prospectively maintained prostate biopsy databases at 10 urology centers. Men with Prostate Health Index and MRI-guided targeted and systematic prostate biopsy perf...
A total of 1,215 men were analyzed. Prostate cancer and clinically significant prostate cancer were diagnosed in 51% (617/1,215) and 35% (422/1,215) of men, respectively. Clinically significant prosta...
Prostate Health Index density outperformed Prostate Health Index or PSA density in clinically significant prostate cancer detection in men with multiparametric MRI performed, and further reduced unnec...